Symbotic Director Sells $22,200 in Stock Through Planned Trading Program
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Director Merline Saintil of Symbotic has reported a sale of 600 shares of Class A Common Stock at a price of $37 per share on June 20, 2025. The transaction was executed through a pre-planned Rule 10b5-1 trading plan established on February 25, 2025.
Following the transaction, Saintil retains beneficial ownership of 77,413 shares held directly. The sale represents a minor reduction in the director's holdings, suggesting routine portfolio management rather than a significant shift in position.
Key details:
- Transaction was conducted under a Rule 10b5-1 trading plan, demonstrating pre-planned nature of the sale
- Total transaction value: $22,200
- Form 4 filed within required reporting timeline
- No derivative securities transactions reported
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 600 | $37.00 | $22K |
Footnotes (1)
- F1. This transaction was executed pursuant to a trading plan entered into by the Reporting Person on February 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was SYM Director Saintil's stock sale part of a 10b5-1 trading plan?
What is Merline Saintil's role at SYM?
AI-generated analysis. How Rhea-AI works. Not financial advice.